Get the Stockscreener App
2.25
0.44%
-0.010
Aytu Biopharma Inc stock is traded at $2.25, with a volume of 50,498.
It is down -0.44% in the last 24 hours and down -9.27% over the past month.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
See More
Previous Close:
$2.26
Open:
$2.24
24h Volume:
50,498
Relative Volume:
0.18
Market Cap:
$20.20M
Revenue:
$93.76M
Net Income/Loss:
$-13.68M
P/E Ratio:
-0.8555
EPS:
-2.63
Net Cash Flow:
$8.77M
1W Performance:
-4.26%
1M Performance:
-9.27%
6M Performance:
+78.57%
1Y Performance:
-6.25%
1-Day Range:
$2.20
$2.26
1-Week Range:
$2.20
$2.395
52-Week Range:
$0.95
$2.85
Aytu Biopharma Inc Stock (AYTU) Company Profile
Name
Aytu Biopharma Inc
Sector
Phone
(720) 437-6580
Address
7900 E. UNION AVENUE, DENVER
Compare AYTU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.25 | 20.29M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Lake Street | Buy |
| Jun-30-25 | Initiated | Ascendiant Capital Markets | Buy |
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-29-20 | Initiated | H.C. Wainwright | Buy |
Aytu Biopharma Inc Stock (AYTU) Latest News
Will Aytu BioPharma Inc. benefit from government policy2025 Pullback Review & Community Trade Idea Sharing Platform - 강소기업뉴스
is aytu biopharma inc. trending in predictive chart models2025 Key Lessons & Daily Volume Surge Trade Alerts - Newser
Key metrics from Aytu BioPharma Inc.’s quarterly dataWatch List & Real-Time Market Sentiment Reports - Newser
Custom watchlist performance reports with Aytu BioPharma Inc.2025 Momentum Check & Low Risk High Win Rate Picks - Newser
What data driven models say about Aytu BioPharma Inc.’s futureWeekly Volume Report & High Conviction Buy Zone Picks - Newser
Will Aytu BioPharma Inc. rebound enough to break evenJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
How to recover losses in Aytu BioPharma Inc. stockM&A Rumor & Community Trade Idea Sharing Platform - Newser
Is Aytu BioPharma Inc. showing signs of accumulationWatch List & Consistent Growth Equity Picks - Newser
Should you avoid Aytu BioPharma Inc. stock right nowTrade Exit Report & AI Optimized Trade Strategies - خودرو بانک
Is Aytu BioPharma Inc. stock a top performer YTDJuly 2025 Drop Watch & Consistent Profit Focused Trading Strategies - خودرو بانک
Does Aytu BioPharma Inc. align with a passive investing strategyEarnings Miss & AI Powered Buy and Sell Recommendations - خودرو بانک
Is Aytu BioPharma Inc. a defensive stockJuly 2025 Levels & Free Weekly Watchlist of Top Performers - خودرو بانک
Will Aytu BioPharma Inc. see short term momentumWeekly Trade Review & High Win Rate Trade Alerts - Newser
Can Aytu BioPharma Inc. benefit from deglobalizationJuly 2025 Market Mood & Real-Time Market Trend Scan - خودرو بانک
Analyzing Aytu BioPharma Inc. with risk reward ratio chartsMarket Risk Analysis & Weekly High Potential Alerts - Newser
Will Aytu BioPharma Inc. continue its uptrendPortfolio Return Summary & Real-Time Buy Signal Alerts - Newser
Is Aytu BioPharma Inc. stock entering bullish territoryJuly 2025 Opening Moves & Capital Protection Trade Alerts - Newser
Is Aytu BioPharma Inc. forming a bottoming baseEarnings Beat & Growth Focused Stock Reports - Newser
Combining price and volume data for Aytu BioPharma Inc.2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Certain Stock Options of Aytu BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 4-SEP-2025. - MarketScreener
Live market analysis of Aytu BioPharma Inc.July 2025 Recap & Growth Focused Stock Reports - Newser
Risk vs reward if holding onto Aytu BioPharma Inc.Earnings Performance Report & AI Driven Stock Movement Reports - Newser
Fed Meeting: What hedge funds are buying Aytu BioPharma Inc.2025 Valuation Update & Scalable Portfolio Growth Ideas - خودرو بانک
What machine learning models say about Aytu BioPharma Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - Newser
Will Aytu BioPharma Inc. benefit from macro trendsWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
What hedge funds are buying Aytu BioPharma Inc.Weekly Risk Report & Daily Chart Pattern Signal Reports - خودرو بانک
Why Aytu BioPharma Inc. is moving todayShare Buyback & Free Daily Entry Point Trade Alerts - Newser
How to manage a losing position in Aytu BioPharma Inc.July 2025 Decliners & Low Drawdown Investment Strategies - Newser
Is Aytu BioPharma Inc. trending in predictive chart modelsMarket Sentiment Report & Daily Profit Focused Screening - Newser
What is Aytu BioPharma Inc.’s valuation compared to sector2025 Technical Patterns & Smart Money Movement Tracker - خودرو بانک
VIX Spike: Is Aytu BioPharma Inc. still a buy after recent gains2025 Momentum Check & Safe Entry Trade Reports - خودرو بانک
Is Aytu BioPharma Inc. still a buy after recent gainsQuarterly Market Review & Growth Focused Stock Reports - خودرو بانک
Detecting price anomalies in Aytu BioPharma Inc. with AIVolume Spike & Weekly Chart Analysis and Trade Guides - Newser
Fibonacci Levels Suggest Recovery for Aytu BioPharma Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Aytu Biopharma Inc Stock (AYTU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aytu Biopharma Inc Stock (AYTU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
3.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):